-
Quaker Chemical Corporation recently reported that for the second quarter of 2026, sales were US$532.55 million with net income of US$26.84 million, a return to profitability compared to a net loss a year earlier, and the Board approved a higher quarterly dividend of US$0.53 per share payable on October 30, 2026.
-
Alongside these results, Quaker Chemical filed new shelf registrations, including a US$563.93 million ESOP-related common share offering, highlighting ongoing capital planning and employee ownership initiatives that may influence how investors view its balance between growth investment and shareholder returns.
-
We'll now examine how Quaker Chemical's return to profitability in the latest quarter shapes and potentially reinforces its existing investment narrative.
Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.
Quaker Chemical Investment Narrative Recap
To own Quaker Chemical, you need to believe in its ability to translate specialty fluids, Asia expansion and cost savings into resilient earnings, despite exposure to cyclical automotive and metalworking markets. The Q2 2026 return to profitability and higher dividend support that thesis but do not eliminate key near term concerns around EMEA volatility, leverage and margin pressure from input costs, which remain central risks to watch.
The most relevant recent development here is the increased quarterly dividend to US$0.53 per share, payable on October 30, 2026. Paired with resumed profitability, this capital return sits alongside fresh shelf registrations and an ESOP related offering, giving a clearer view of how Quaker Chemical is balancing reinvestment, employee ownership and direct payouts, which all feed into how investors think about its near term earnings power and risk profile.
Yet behind the improved earnings, investors should still be aware of how persistent margin pressure or EMEA weakness could...
Read the full narrative on Quaker Chemical (it's free!)
Quaker Chemical's narrative projects $2.2 billion revenue and $206.0 million earnings by 2029. This requires 3.8% yearly revenue growth and about a $108 million earnings increase from $97.6 million today.
Uncover how Quaker Chemical's forecasts yield a $179.86 fair value , a 12% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were expecting revenue near US$2.2 billion and earnings around US$329 million by 2029, which is far more upbeat than consensus and leans heavily on faster Asia growth and margin gains than the risks around customer concentration and EV driven product shifts might suggest, so you should weigh these contrasting views against the latest results and consider how your own expectations might change from here.
Explore 3 other fair value estimates on Quaker Chemical - why the stock might be worth 8% less than the current price!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
-
A great starting point for your Quaker Chemical research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
-
Our free Quaker Chemical research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Quaker Chemical's overall financial health at a glance.
Curious About Other Options?
Our top stock finds are flying under the radar-for now. Get in early:
-
Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
-
The future of work is here. Discover the 36 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
-
Find 55 companies with promising cash flow potential yet trading below their fair value .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KWR .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
